 |
|
|
| |
Peginterferon Lambda-1a (Lambda) Compared With Peginterferon Alfa-2a (Alfa) in
Treatment-Naive Patients With HCV Genotypes 1 or 4: SVR24 Results From EMERGE Phase 2b
|
| |
| |
Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
Muir A1 for the EMERGE Study Group; Hillson J,2 Gray T,2 Xu D,3 Ishak L,2
Freeman J,2 Fontana D,2 Horga A,3 Lopez-Talavera JC3
1Duke University Medical Center, Durham, NC; 2ZymoGenetics, Bristol-Myers Squibb, Seattle, WA; 3Research and Development, Bristol-Myers Squibb, Wallingford, CT
|
| |
|
|
|
|
|
